Transplantation Therapeutics Research: Talks about leading products and key unmet needs within the market

This leads to an anti-graft immune response that involves T cells invading the new tissue, multiplying, and recruiting more immune cells to the transplant site in order to remove this foreign body.

Pune, India - March 14, 2018 /MarketersMedia/ —

In 2015 a total of 127,000 transplantations were performed worldwide, an increase of 5.8% from 2014, with 33,000 of these occurring in the EU and 32,000 in the US. Approximately 60% of these were kidney transplants, with liver, heart, lung, pancreas and small bowel transplantations accounting for the other most common procedures (Dominguez-Gil and Matesanz, 2017). When a graft is transplanted from a genetically non-identical individual, the recipient’s immune system recognizes the graft as foreign.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-transplantation-therapeutics-a-highly-innovative-pipeline-with-a-range-of-adaptive-and-innate-immune-targeting-programs-focusing-on-graft-versus-host-disease-and-kidney-transplantation
Reasons To Buy
• Appreciate the current clinical and commercial landscapes by considering disease symptoms, pathogenesis, etiology, co-morbidities and complications, epidemiology, diagnosis, prognosis and treatment options for transplantation rejection.
• Identify leading products and key unmet needs within the market.
• Recognize trends in pipeline innovation by analyzing therapies by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary molecular target matrix assessment, first-in-class targets in the pipeline have been assessed and ranked according to clinical potential.
• Consider first-in-class pipeline products with no prior involvement in licensing and co-development deals, which may represent potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/935560
Scope
• There is a need for therapies that can achieve graft-specific immunosuppression, without having a general effect on the wider immune system. Which therapies and technologies currently in development are most likely to achieve this?
• There are 63 distinct first-in-class molecular targets in development for transplantation. Which of these hold the strongest potential in the clinic, and which are closest to reaching the market?
• How effective are current therapies for these indications, and how have they been able to improve the general prognosis in recent decades?
• Which molecule types and molecular targets are most prominent across transplantation therapy?
• Which specific types of transplantation are being most heavily studied across the pharmaceutical pipeline?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935560

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/transplantation-therapeutics-research-talks-about-leading-products-and-key-unmet-needs-within-the-market/314334

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-transplantation-therapeutics-a-highly-innovative-pipeline-with-a-range-of-adaptive-and-innate-immune-targeting-programs-focusing-on-graft-versus-host-disease-and-kidney-transplantation%20%20

Source: MarketersMedia

Release ID: 314334

Latest News

Mystery around disappearance of Chinese star Fan Bingbing

Sep 25, 2018

BEIJING — X-Men star Fan Bingbing's Beijing management office is dark and abandoned. Her birthday passed almost unremarked in China's hyper-adrenalized social media environment. For one of China's best known stars and a rising Hollywood actress, Fan's vanishing is stunning, coming amid vague allegations of tax fraud and possibly other infractions that could have put her at odds with Chinese authorities. Fan has starred in dozens of movies and TV series in China and is best known internationally for her role as Blink in 2014's "X-Men: Days of Future Past," a cameo in the Chinese version of "Iron Man 3,"...

Meghan reveals 'something blue' she wore at royal wedding

Sep 25, 2018

LONDON — It's an old tradition that a bride should have something old, something new, something borrowed and something blue on her wedding day, and the Duchess of Sussex followed at least part of that when she married Prince Harry. The former Meghan Markle has revealed in a television documentary that she had a piece of blue fabric from the dress she wore on her first date with Harry sewn into her wedding dress. She made the comments while discussing the dress in a documentary about Queen Elizabeth II called "Queen of the World." She didn't say whether she also...

Comcast beats Fox in Sky auction with $39B bid

Sep 25, 2018

LONDON — Comcast has emerged as the top bidder for European broadcaster Sky after a rare auction held by British regulators. After three rounds of secret bidding on Friday and Saturday, Comcast offered the higher price of 17.28 pounds ($22.58) per share for Sky, the equivalent of nearly 30 billion pounds ($39 billion). Rival 21st Century Fox offered 15.67 ($20.47) per share. In a statement, Sky recommended that shareholders accept Comcast's offer and sell their shares immediately. Comcast said it hoped to complete the takeover by the end of October. "Sky is a wonderful company with a great platform, tremendous...

Singer Elton John and partner win libel judgment

Sep 25, 2018

LONDON — Singer Elton John and partner David Furnish have accepted an apology and undisclosed libel damages over a newspaper report that their dog severely injured a child while on a play date. The pair brought the case against News Group Newspapers, which owns The Sun and Sun on Sunday, over a story in February that claimed the dog inflicted "Freddy Krueger-like injuries" — a reference to the violent character in the "Nightmare on Elm Street." The couple were not at London's High Court on Friday but their lawyer, Jenny Afia, says the allegation was false and that NGN agreed...

Fox-Comcast battle to buy Sky to be settled by auction in UK

Sep 25, 2018

LONDON — Comcast and 21st Century Fox will settle their battle for control of broadcaster Sky through a rare auction designed to put an end to months of offers and counteroffers from the American media empires seeking a foothold in the European pay TV market. The auction will begin after the London stock market's close on Friday and end sometime Saturday evening following a maximum of three rounds of bidding, said Britain's regulator, the Takeover Panel. Fox started the bidding war last December, when it sought to acquire the 61 percent of Sky it doesn't already own. Comcast has since...

About Us

Frontal Report is an emerging leader in all forms of media. We aim to be the leading news brand for readers around the world.

Contact us: sales[at]frontalreport.com

Subscribe Now!